Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer

Chuo, Dongyu; Lin, Dong; Yin, Mingdi

doi:10.2147/pgpm.s282653

Cited by 1 publication

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lactate enters the cardiomyocytes through monocarboxylic anion transporter 4 (MCT4) and is converted into pyruvate using lactate dehydrogenase (LDH). The resultant pyruvate undergoes a similar fate as the glycolytic-derived pyruvate described in Section 3.2 [50,51].…”

Section: Lactatementioning

confidence: 89%

Cardiac Metabolism and MiRNA Interference

Sumaiya

Ponnusamy

Natarajaseenivasan

et al. 2022

IJMS

View full text Add to dashboard Cite

The aberrant increase in cardio-metabolic diseases over the past couple of decades has drawn researchers’ attention to explore and unveil the novel mechanisms implicated in cardiometabolic diseases. Recent evidence disclosed that the derangement of cardiac energy substrate metabolism plays a predominant role in the development and progression of chronic cardiometabolic diseases. Hence, in-depth comprehension of the novel molecular mechanisms behind impaired cardiac metabolism-mediated diseases is crucial to expand treatment strategies. The complex and dynamic pathways of cardiac metabolism are systematically controlled by the novel executor, microRNAs (miRNAs). miRNAs regulate target gene expression by either mRNA degradation or translational repression through base pairing between miRNA and the target transcript, precisely at the 3’ seed sequence and conserved heptametrical sequence in the 5’ end, respectively. Multiple miRNAs are involved throughout every cardiac energy substrate metabolism and play a differential role based on the variety of target transcripts. Novel theoretical strategies have even entered the clinical phase for treating cardiometabolic diseases, but experimental evidence remains inadequate. In this review, we identify the potent miRNAs, their direct target transcripts, and discuss the remodeling of cardiac metabolism to cast light on further clinical studies and further the expansion of novel therapeutic strategies. This review is categorized into four sections which encompass (i) a review of the fundamental mechanism of cardiac metabolism, (ii) a divulgence of the regulatory role of specific miRNAs on cardiac metabolic pathways, (iii) an understanding of the association between miRNA and impaired cardiac metabolism, and (iv) summary of available miRNA targeting therapeutic approaches.

show abstract

Section: Lactatementioning

confidence: 89%